Cargando…
Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model
OBJECTIVE: To model the long-term cost-effectiveness of consuming milk powder fortified with potassium to decrease systolic blood pressure (SBP) and prevent cardiovascular events. DESIGN: A best case scenario analysis using a Markov model was conducted. PARTICIPANTS: 8.67% of 50–79 year olds who reg...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623478/ https://www.ncbi.nlm.nih.gov/pubmed/28951410 http://dx.doi.org/10.1136/bmjopen-2017-017136 |
_version_ | 1783268096604110848 |
---|---|
author | Dainelli, Livia Xu, Tingting Li, Min Zimmermann, Diane Fang, Hai Wu, Yangfeng Detzel, Patrick |
author_facet | Dainelli, Livia Xu, Tingting Li, Min Zimmermann, Diane Fang, Hai Wu, Yangfeng Detzel, Patrick |
author_sort | Dainelli, Livia |
collection | PubMed |
description | OBJECTIVE: To model the long-term cost-effectiveness of consuming milk powder fortified with potassium to decrease systolic blood pressure (SBP) and prevent cardiovascular events. DESIGN: A best case scenario analysis using a Markov model was conducted. PARTICIPANTS: 8.67% of 50–79 year olds who regularly consume milk in China, including individuals with and without a prior diagnosis of hypertension. INTERVENTION: The model simulated the potential impact of a daily intake of two servings of milk powder fortified with potassium (+700 mg/day) vs the consumption of a milk powder without potassium fortification, assuming a market price equal to 0.99 international dollars (intl$; the consumption of a milk powder without potassium fortification, assuming a market price equal to intl$0.99 for the latter and to intl$1.12 for the first (+13.13%). Both deterministic and probabilistic sensitivity analyses were conducted to test the robustness of the results. MAIN OUTCOME MEASURES: Estimates of the incidence of cardiovascular events and subsequent mortality in China were derived from the literature as well as the effect of increasing potassium intake on blood pressure. The incremental cost-effectiveness ratio (ICER) was used to determine the cost-effectiveness of a milk powder fortified with potassium taking into consideration the direct medical costs associated with the cardiovascular events, loss of working days and health utilities impact. RESULTS: With an ICER equal to int$4711.56 per QALY (quality-adjusted life year) in the best case scenario and assuming 100% compliance, the daily consumption of a milk powder fortified with potassium shown to be a cost-effective approach to decrease SBP and reduce cardiovascular events in China. Healthcare savings due to prevention would amount to intl$8.41 billion. Sensitivity analyses showed the robustness of the results. CONCLUSION: Together with other preventive interventions, the consumption of a milk powder fortified with potassium could represent a cost-effective strategy to attenuate the rapid rise in cardiovascular burden among the 50–79 year olds who regularly consume milk in China. |
format | Online Article Text |
id | pubmed-5623478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-56234782017-10-10 Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model Dainelli, Livia Xu, Tingting Li, Min Zimmermann, Diane Fang, Hai Wu, Yangfeng Detzel, Patrick BMJ Open Health Economics OBJECTIVE: To model the long-term cost-effectiveness of consuming milk powder fortified with potassium to decrease systolic blood pressure (SBP) and prevent cardiovascular events. DESIGN: A best case scenario analysis using a Markov model was conducted. PARTICIPANTS: 8.67% of 50–79 year olds who regularly consume milk in China, including individuals with and without a prior diagnosis of hypertension. INTERVENTION: The model simulated the potential impact of a daily intake of two servings of milk powder fortified with potassium (+700 mg/day) vs the consumption of a milk powder without potassium fortification, assuming a market price equal to 0.99 international dollars (intl$; the consumption of a milk powder without potassium fortification, assuming a market price equal to intl$0.99 for the latter and to intl$1.12 for the first (+13.13%). Both deterministic and probabilistic sensitivity analyses were conducted to test the robustness of the results. MAIN OUTCOME MEASURES: Estimates of the incidence of cardiovascular events and subsequent mortality in China were derived from the literature as well as the effect of increasing potassium intake on blood pressure. The incremental cost-effectiveness ratio (ICER) was used to determine the cost-effectiveness of a milk powder fortified with potassium taking into consideration the direct medical costs associated with the cardiovascular events, loss of working days and health utilities impact. RESULTS: With an ICER equal to int$4711.56 per QALY (quality-adjusted life year) in the best case scenario and assuming 100% compliance, the daily consumption of a milk powder fortified with potassium shown to be a cost-effective approach to decrease SBP and reduce cardiovascular events in China. Healthcare savings due to prevention would amount to intl$8.41 billion. Sensitivity analyses showed the robustness of the results. CONCLUSION: Together with other preventive interventions, the consumption of a milk powder fortified with potassium could represent a cost-effective strategy to attenuate the rapid rise in cardiovascular burden among the 50–79 year olds who regularly consume milk in China. BMJ Publishing Group 2017-09-25 /pmc/articles/PMC5623478/ /pubmed/28951410 http://dx.doi.org/10.1136/bmjopen-2017-017136 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Health Economics Dainelli, Livia Xu, Tingting Li, Min Zimmermann, Diane Fang, Hai Wu, Yangfeng Detzel, Patrick Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model |
title | Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model |
title_full | Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model |
title_fullStr | Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model |
title_full_unstemmed | Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model |
title_short | Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model |
title_sort | cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in china: a markov model |
topic | Health Economics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623478/ https://www.ncbi.nlm.nih.gov/pubmed/28951410 http://dx.doi.org/10.1136/bmjopen-2017-017136 |
work_keys_str_mv | AT dainellilivia costeffectivenessofmilkpowderfortifiedwithpotassiumtodecreasebloodpressureandpreventcardiovasculareventsamongtheadultpopulationinchinaamarkovmodel AT xutingting costeffectivenessofmilkpowderfortifiedwithpotassiumtodecreasebloodpressureandpreventcardiovasculareventsamongtheadultpopulationinchinaamarkovmodel AT limin costeffectivenessofmilkpowderfortifiedwithpotassiumtodecreasebloodpressureandpreventcardiovasculareventsamongtheadultpopulationinchinaamarkovmodel AT zimmermanndiane costeffectivenessofmilkpowderfortifiedwithpotassiumtodecreasebloodpressureandpreventcardiovasculareventsamongtheadultpopulationinchinaamarkovmodel AT fanghai costeffectivenessofmilkpowderfortifiedwithpotassiumtodecreasebloodpressureandpreventcardiovasculareventsamongtheadultpopulationinchinaamarkovmodel AT wuyangfeng costeffectivenessofmilkpowderfortifiedwithpotassiumtodecreasebloodpressureandpreventcardiovasculareventsamongtheadultpopulationinchinaamarkovmodel AT detzelpatrick costeffectivenessofmilkpowderfortifiedwithpotassiumtodecreasebloodpressureandpreventcardiovasculareventsamongtheadultpopulationinchinaamarkovmodel |